Literature DB >> 28778288

Adverse Reactions to Transfusion of Blood Products and Best Practices for Prevention.

Susan K Frazier1, Jacob Higgins2, Andrew Bugajski2, Allison R Jones3, Michelle R Brown4.   

Abstract

Transfusion, a common practice in critical care, is not without complication. Acute adverse reactions to transfusion occur within 24 hours and include acute hemolytic transfusion reaction, febrile nonhemolytic transfusion reaction, allergic and anaphylactic reactions, and transfusion-related acute lung injury, transfusion-related infection or sepsis, and transfusion-associated circulatory overload. Delayed transfusion adverse reactions develop 48 hours or more after transfusion and include erythrocyte and platelet alloimmunization, delayed hemolytic transfusion reactions, posttransfusion purpura, transfusion-related immunomodulation, transfusion-associated graft versus host disease, and, with long-term transfusion, iron overload. Clinical strategies may reduce the likelihood of reactions and improve patient outcomes.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adverse transfusion reactions; Blood components; Restrictive transfusion strategy; TACO; TRALI; Transfusion

Mesh:

Year:  2017        PMID: 28778288     DOI: 10.1016/j.cnc.2017.04.002

Source DB:  PubMed          Journal:  Crit Care Nurs Clin North Am        ISSN: 0899-5885            Impact factor:   1.326


  14 in total

1.  A clinical coagulopathy score concurrent with viscoelastic testing defines opportunities to improve hemostatic resuscitation and enhance blood product utilization during liver transplantation.

Authors:  Alexander C Schulick; Hunter B Moore; Carson B Walker; Hillary Yaffe; James J Pomposelli; Fareed Azam; Michael Wachs; Thomas Bak; Peter Kennealey; Kendra Conzen; Megan Adams; Thomas Pshak; Rashikh Choudhury; Michael P Chapman; Elizabeth A Pomfret; Trevor L Nydam
Journal:  Am J Surg       Date:  2020-09-01       Impact factor: 2.565

2.  Antibodies against human neutrophil antigens in non-transfused women with red blood cell alloimmunisation induced by pregnancy.

Authors:  Juliana Oliveira Martins; Elyse Moritz; Samira A Abbas; Larissa B Lopes; Melca M O Barros; Akemi K Chiba; Dante M Langhi; José O Bordin
Journal:  Blood Transfus       Date:  2020-10-14       Impact factor: 3.443

3.  Erythropoietic properties of human induced pluripotent stem cells-derived red blood cells in immunodeficient mice.

Authors:  Jiusheng Deng; Moira Lancelot; Ryan Jajosky; Qiaomei Deng; Kristin Deeb; Natia Saakadze; Yongxing Gao; David Jaye; Senquan Liu; Sean R Stowell; Linzhao Cheng; John D Roback
Journal:  Am J Hematol       Date:  2021-11-24       Impact factor: 10.047

Review 4.  The Non-Hemostatic Aspects of Transfused Platelets.

Authors:  Caroline Sut; Sofiane Tariket; Cécile Aubron; Chaker Aloui; Hind Hamzeh-Cognasse; Philippe Berthelot; Sandrine Laradi; Andreas Greinacher; Olivier Garraud; Fabrice Cognasse
Journal:  Front Med (Lausanne)       Date:  2018-02-27

Review 5.  How do I see the production of engineered blood cells available for transfusion?

Authors:  Olivier Garraud
Journal:  Transfus Apher Sci       Date:  2020-06-29       Impact factor: 1.764

Review 6.  On the Way to in vitro Platelet Production.

Authors:  Catherine Strassel; Christian Gachet; François Lanza
Journal:  Front Med (Lausanne)       Date:  2018-08-28

Review 7.  Convalescent Plasma Therapy for Management of COVID-19: Perspectives and Deployment in the Current Global Pandemic.

Authors:  Nandeeta Samad; Temitayo Eniola Sodunke; Hasan Al Banna; Ashmita Sapkota; Aneeka Nawar Fatema; Katia Iskandar; Dilshad Jahan; Timothy Craig Hardcastle; Tanzina Nusrat; Tajkera Sultana Chowdhury; Mainul Haque
Journal:  Risk Manag Healthc Policy       Date:  2020-11-23

Review 8.  Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 Era.

Authors:  Gary H Lyman; Nicole M Kuderer; Matti Aapro
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

9.  Red blood cell prescription and recognition of transfusion reactions by pediatricians.

Authors:  Carlos João Schaffhausser Filho; João Carlos Pina Faria; Fabíola Isabel Suano-Souza; Roseli Oselka Saccardo Sarni
Journal:  Einstein (Sao Paulo)       Date:  2020-09-14

10.  The efficacy and safety of intravenous tranexamic acid in anterior cruciate ligament reconstruction: A randomized controlled trial protocol.

Authors:  Hongyao Xu; Pengcheng Xia; Xiangjie Zou; He Huang
Journal:  Medicine (Baltimore)       Date:  2020-08-21       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.